ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,001 filers reported holding ASTRAZENECA PLC in Q2 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $200,236,121 | -29.4% | 2,884,831 | -31.0% | 1.02% | -35.2% |
| Q4 2022 | $283,468,477 | +49.4% | 4,180,951 | +20.8% | 1.58% | +42.1% |
| Q3 2022 | $189,750,000 | +1003.3% | 3,460,062 | +1229.3% | 1.11% | +2313.0% |
| Q2 2022 | $17,198,000 | +108.2% | 260,300 | +56.7% | 0.05% | +31.4% |
| Q1 2021 | $8,261,000 | -97.4% | 166,155 | -97.4% | 0.04% | -97.4% |
| Q4 2020 | $317,318,000 | -0.6% | 6,347,649 | +9.0% | 1.32% | -6.8% |
| Q3 2020 | $319,075,000 | +0.1% | 5,822,536 | -3.4% | 1.42% | -8.5% |
| Q2 2020 | $318,883,000 | +13.1% | 6,029,185 | -4.5% | 1.55% | -10.1% |
| Q1 2020 | $282,028,000 | +0.9% | 6,314,996 | +12.6% | 1.73% | +18.9% |
| Q4 2019 | $279,590,000 | -4.4% | 5,607,500 | -14.5% | 1.45% | -9.1% |
| Q3 2019 | $292,460,000 | +15.5% | 6,561,801 | +7.0% | 1.60% | +17.8% |
| Q2 2019 | $253,267,000 | +0.2% | 6,135,344 | -1.9% | 1.36% | -0.9% |
| Q1 2019 | $252,774,000 | – | 6,252,146 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |